Maria M Brooks Selected Research

Percutaneous Coronary Intervention

1/2021	Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials.
11/2020	Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization.
1/2016	Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.
4/2009	Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria M Brooks Research Topics

Disease

7	Atherosclerosis 05/2024 - 04/2011
7	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 04/2011
5	Myocardial Infarction 01/2021 - 01/2016
5	Type 2 Diabetes Mellitus (MODY) 11/2020 - 12/2009
5	Stroke (Strokes) 04/2020 - 07/2016
4	Hypertension (High Blood Pressure) 01/2021 - 04/2011
4	Coronary Disease (Coronary Heart Disease) 11/2020 - 04/2009
4	Infections 01/2020 - 12/2010
4	Atrial Fibrillation 01/2020 - 01/2017
4	Coronary Artery Disease (Coronary Atherosclerosis) 07/2017 - 09/2013
3	COVID-19 11/2021 - 08/2021
3	Hemorrhage 11/2021 - 01/2017
3	Diabetes Mellitus 11/2020 - 01/2017
2	Inflammation (Inflammations) 09/2022 - 08/2011
2	Vascular Diseases (Vascular Disease) 01/2022 - 01/2020
2	Thrombosis (Thrombus) 11/2021 - 08/2011
2	Critical Illness (Critically Ill) 08/2021 - 08/2021
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 08/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2020 - 01/2020
2	Ischemic Stroke 01/2020 - 01/2017
2	Transient Ischemic Attack 01/2020 - 01/2020
2	Pneumonia (Pneumonitis) 01/2020 - 11/2010
2	Heart Failure 01/2020 - 08/2017
2	Chronic Renal Insufficiency 01/2019 - 01/2016
2	Overweight 01/2013 - 01/2013
2	Weight Loss (Weight Reduction) 01/2013 - 01/2013
2	Insulin Resistance 01/2013 - 08/2011
1	Atrophy 11/2023
1	Dysuria 11/2023
1	Pain (Aches) 11/2023
1	Carotid Artery Diseases 10/2023
1	Body Weight (Weight, Body) 11/2021
1	Idiopathic Pulmonary Fibrosis 11/2021
1	Cognitive Dysfunction 01/2021
1	Abdominal Obesity 01/2021
1	Rare Diseases (Rare Disease) 11/2020
1	Shock 10/2020
1	Thromboembolism 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2019
1	Neutropenia 03/2018
1	Cytopenia 03/2018
1	Bacterial Infections (Bacterial Infection) 03/2018
1	Leukopenia 03/2018
1	Legionnaires' Disease (Legionnaire's Disease) 01/2018
1	von Willebrand Diseases (von Willebrand's Disease) 08/2017
1	Liver Neoplasms (Liver Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

5	Insulin (Novolin)FDA Link 08/2017 - 12/2009
4	LipidsIBA 09/2022 - 04/2011
4	Warfarin (Coumadin)FDA LinkGeneric 04/2020 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 08/2011
3	C-Reactive ProteinIBA 01/2022 - 07/2016
3	AnticoagulantsIBA 11/2021 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2011
3	N-formylmethionylphenylalanine (FMP)IBA 01/2021 - 01/2017
2	HDL LipoproteinsIBA 05/2024 - 09/2022
2	Estrogens (Estrogen)FDA Link 11/2023 - 01/2020
2	oxidized low density lipoproteinIBA 10/2023 - 11/2020
2	apixabanIBA 11/2021 - 01/2020
2	Heparin (Liquaemin)FDA LinkGeneric 08/2021 - 08/2021
2	LDL CholesterolIBA 11/2020 - 04/2011
2	Estradiol (Delestrogen)FDA LinkGeneric 10/2020 - 05/2016
2	Dabigatran FDA Link 01/2020 - 01/2017
2	PesticidesIBA 01/2017 - 11/2015
2	AdipokinesIBA 07/2016 - 01/2016
2	HDL CholesterolIBA 07/2016 - 04/2011
2	AdiponectinIBA 01/2013 - 01/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2023
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021
1	Sulfamethoxazole FDA LinkGeneric 11/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2021
1	Doxycycline (Periostat)FDA LinkGeneric 11/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 11/2021
1	Trimethoprim (Proloprim)FDA LinkGeneric 11/2021
1	emicizumabIBA 11/2020
1	factor VIII-Fc fusion proteinIBA 11/2020
1	Transcription Factors (Transcription Factor)IBA 10/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	RivaroxabanIBA 01/2020
1	Conjugated (USP) Estrogens (Premarin)FDA Link 01/2019
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 03/2018
1	Azathioprine (Imuran)FDA LinkGeneric 03/2018
1	Drinking WaterIBA 01/2018
1	DiureticsIBA 08/2017
1	von Willebrand FactorIBA 08/2017
1	Fibrin Fibrinogen Degradation ProductsIBA 07/2017

Therapy/Procedure

10	Therapeutics 11/2021 - 12/2009
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 04/2009
4	Percutaneous Coronary Intervention 01/2021 - 04/2009
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 11/2010
2	Transplantation 03/2018 - 12/2010
2	Heart Transplantation (Grafting, Heart) 09/2012 - 12/2010
1	Critical Care (Surgical Intensive Care) 08/2021
1	Length of Stay 01/2020
1	Glycemic Control 10/2019
1	Myocardial Revascularization 01/2019